Want to see IN:BOROSCI full AI Analyst Report?
Top Page
Borosil Scientific Limited
(BOROSCI)
Select Model
Select Model
Rating:60Neutral
Price Target:
₹132.00
▼(-2.33% Downside)
Action:Downgraded
Date:06/30/26
The score is primarily supported by strong financial positioning (notably a conservatively leveraged balance sheet) and solid reported earnings growth. It is held back by materially weaker operating/free cash flow in FY2026 and a high P/E multiple, while technical confirmation is not available due to missing indicator data.
Positive Factors
Revenue and Earnings Growth
Strong FY2026 revenue growth alongside higher operating profit and net income indicates expanding demand and improved earnings capacity. If sustained, this growth can strengthen the company’s market position and provide internal resources for product development, distribution, and business expansion.
Negative Factors
Weakening Cash Generation
The sharp decline in operating and free cash flow means reported profit is converting into cash less reliably. Persistent weakness could constrain internally funded growth, reduce flexibility in working-capital management, and make earnings quality less dependable over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Earnings Growth
Strong FY2026 revenue growth alongside higher operating profit and net income indicates expanding demand and improved earnings capacity. If sustained, this growth can strengthen the company’s market position and provide internal resources for product development, distribution, and business expansion.
Read all positive factors
Borosil Scientific Limited (BOROSCI) vs. iShares MSCI India ETF (INDA)
Market Cap
₹11.31B
Dividend YieldN/A
Average Volume (3M)7.09K
Price to Earnings (P/E)25.8
Beta (1Y)1.15
Revenue Growth11.31%
EPS Growth144.96%
CountryIN
Employees631
SectorGeneral
Sector StrengthN/A
IndustryPackaging & Containers
Share Statistics
EPS (TTM)1.29
Shares Outstanding88,951,520
10 Day Avg. Volume5,112
30 Day Avg. Volume7,089
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)2.08
Price to Sales (P/S)1.96
P/FCF Ratio65.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Borosil Scientific Limited Business Overview & Revenue Model
Company Description
Established in 1962 and headquartered in Mumbai, India, Borosil Scientific Limited is a specialist in the manufacturing and distribution of a wide array of laboratory products. Its comprehensive portfolio includes essential lab glassware and consu...
How the Company Makes Money
Borosil Scientific Limited primarily makes money by selling scientific and laboratory products to institutional and commercial customers. Key revenue streams typically include (1) sales of laboratory glassware and related labware/consumables used ...
Borosil Scientific Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
88
Very Positive
Cash Flow
48
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2025 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 2.35B | 4.67B | 4.37B |
| Gross Profit | 742.34M | 2.01B | 2.06B |
| EBITDA | 293.33M | 632.11M | 604.11M |
| Net Income | 115.63M | 346.14M | 268.04M |
Balance Sheet | |||
| Total Assets | 5.02B | 5.49B | 5.09B |
| Cash, Cash Equivalents and Short-Term Investments | 1.20B | 1.36B | 1.24B |
| Total Debt | 88.69M | 86.30M | 144.38M |
| Total Liabilities | 978.97M | 1.08B | 1.04B |
| Stockholders Equity | 4.04B | 4.41B | 4.04B |
Cash Flow | |||
| Free Cash Flow | 1.04B | 140.08M | 1.06B |
| Operating Cash Flow | 1.23B | 424.61M | 1.20B |
| Investing Cash Flow | -1.12B | -375.50M | -1.15B |
| Financing Cash Flow | -78.18M | -50.56M | -34.01M |
Borosil Scientific Limited Technical Analysis
Negative
135.15
Price Trends
143.38
Negative
141.16
Negative
127.42
Negative
Market Momentum
-3.72
Negative
38.09
Neutral
29.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BOROSCI, the sentiment is Negative. The current price of 135.15 is above the 20-day moving average (MA) of 128.75, below the 50-day MA of 143.38, and above the 200-day MA of 127.42, indicating a bearish trend. The MACD of -3.72 indicates Negative momentum. The RSI at 38.09 is Neutral, neither overbought nor oversold. The STOCH value of 29.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BOROSCI.
Borosil Scientific Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹34.74B | 30.38 | ― | 0.65% | 4.98% | -13.56% | |
70 Outperform | ₹91.79B | 17.93 | ― | 0.67% | 15.51% | 15.99% | |
66 Neutral | ₹22.91B | 29.95 | ― | 0.74% | 14.71% | 14.50% | |
60 Neutral | ₹11.31B | 25.83 | ― | ― | 11.31% | 144.96% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₹49.00B | 7.12 | ― | 0.44% | 10.36% | 128.39% | |
47 Neutral | ₹29.50B | -3.00 | ― | 0.87% | -58.49% | -4440.85% |
* General Sector Average
IN:BOROSCI
Borosil Scientific Limited
125.10
-15.65
-11.12%
IN:JINDALPOLY
Jindal Poly Films Limited
673.55
72.22
12.01%
IN:MOLDTKPAC
Mold Tek Packaging Ltd
676.70
-140.78
-17.22%
IN:TCPLPACK
TCPL Packaging Limited
3,875.20
494.93
14.64%
IN:TIMETECHNO
Time Technoplast Limited
180.90
-54.85
-23.27%
IN:UFLEX
UFlex Limited
653.10
100.76
18.24%
Borosil Scientific Limited Corporate Events
Borosil Scientific Revises Senior Management Structure in Sales Division
Jul 14, 2026
Borosil Scientific Limited has announced a change in its senior managerial structure, disclosing that Sharad Tiwari, previously Head of Sales for domestic and international pharmaceutical primary packaging, is no longer classified as Senior Manage...
Borosil Scientific Shuts Trading Window Ahead of June Quarter Results
Jun 25, 2026
Borosil Scientific Limited has announced the closure of its trading window for designated persons and their immediate relatives from July 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s interna...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.